SI
IHE icon

Stephens Inc’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Stephens Inc’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-7,542
Closed -$407K – 770
2015
Q4 		$407K Buy
7,542
+93
+1% +$4.89K 0.02% 479
2015
Q3 		$368K Buy
7,449
+465
+7% +$26.7K 0.02% 502
2015
Q2 		$407K Sell
6,984
-51
-0.7% -$2.98K 0.02% 543
2015
Q1 		$404K Buy
7,035
+1,530
+28% +$83.7K 0.02% 543
2014
Q4 		$278K Buy
5,505
+120
+2% +$5.85K 0.01% 626
2014
Q3 		$252K Hold
5,385
– – 0.01% 648
2014
Q2 		$243K Sell
5,385
-45
-0.8% -$1.94K 0.01% 706
2014
Q1 		$229K Buy
5,430
+120
+2% +$5.03K 0.01% 677
2013
Q4 		$209K Sell
5,310
-360
-6% -$13.5K 0.01% 761
2013
Q3 		$201K Buy
+5,670
New +$200K 0.01% 722

Other funds holding IHE

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AWA
ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
SFI
SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $2.06B AUM 24.94% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
EAMA
EFG Asset Management (Americas) Miami, Florida $579M AUM 24.22% 1-Year Est. Return

Stephens Inc's IHE Position: Q1 2016 in Review

Stephens Inc sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2016, closing a stake of 7,542 shares — an estimated $407K sold.

Stephens Inc first reported a position in IHE in Q3 2013 and held it in 10 quarters. The position peaked at $407K in Q4 2015. 91 funds tracked by Wall St. Rank hold IHE as of Q1 2016.

  • Stephens Inc reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2016 after selling out during the quarter.
  • Stephens Inc sold 7,542 iShares US Pharmaceuticals ETF shares in Q1 2016, an estimated $407K.
  • Stephens Inc first reported a position in iShares US Pharmaceuticals ETF in Q3 2013 and held it in 10 quarters.
  • Stephens Inc's iShares US Pharmaceuticals ETF position peaked at $407K in Q4 2015.
  • 91 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2016.

Based on Stephens Inc's 13F filing for Q1 2016, filed 5 May 2016.